Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Frontiers in Neurology|December 11, 2023
The relationship of small vessel disease burden on cerebral and regional brain atrophy rates and cognitive performance over one year of follow-up after transient ischemic attackNoaah Reaume, Meaghan Reid, George S Tadros, et al.Frontiers in Neurology|March 7, 2019
Longitudinal Brain Atrophy Rates in Transient Ischemic Attack and Minor Ischemic Stroke Patients and Cognitive ProfilesMuhammad Munir, Jake Ursenbach, Meaghan Reid, et al.International Journal of Stroke : Official Journal of the International Stroke Society|April 27, 2024
A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trialNishita Singh, Carol C Kenney, Ken S Butcher, et al.Stroke|February 14, 2015
Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusionShelagh B Coutts, Véronique Dubuc, Jennifer Mandzia, et al.European Stroke Journal|April 9, 2026
MRI measurement of the delayed secondary ischaemic injury following endovascular thrombectomy: results from the REPERFUSE-NA1 studyGeorge S Tadros, Joachim Fladt, Meng Wang, et al.Stroke|June 19, 2026
Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 TrialNishita Singh, Daniel Strbian, Shabnam Vatanpour, et al.Journal of Alzheimer'S Disease : JAD|December 27, 2021
Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid ProbeStefanie A G Black, Anastasiia A Stepanchuk, George W Templeton, et al.Journal of the American Heart Association|April 16, 2025
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO-2 TrialAmy Y X Yu, Shabnam Vatanpour, Aravind Ganesh, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 17, 2018
Validation of a proteomic biomarker panel to diagnose minor-stroke and transient ischaemic attack: phase 2 of SpecTRA, a large scale translational studyAndrew M Penn, Maximilian B Bibok, Viera K Saly, et al.Neurobiology of Aging|September 28, 2015
Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's diseaseNatalie S Ryan, Geert-Jan Biessels, Lois Kim, et al.Pageof 7